Published in Biochem J on June 15, 2000
Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis. Proc Natl Acad Sci U S A (2003) 1.57
Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis. Mol Genet Metab (2008) 1.03
GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings. Biochim Biophys Acta (2011) 0.97
Beta-galactosidase deficiency: an approach to chaperone therapy. J Inherit Metab Dis (2006) 0.88
Intracellular transport of human lysosomal alpha-mannosidase and alpha-mannosidosis-related mutants. Biochem J (2004) 0.82
A comparative study of cytoplasmic granules imaged by the real-time microscope, Nile Red and Filipin in fibroblasts from patients with lipid storage diseases. J Inherit Metab Dis (2005) 0.80
Molecular Mechanisms of Disease Pathogenesis Differ in Krabbe Disease Variants. Traffic (2016) 0.78
Fluorous iminoalditols: a new family of glycosidase inhibitors and pharmacological chaperones. Chembiochem (2010) 0.77
Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy. Mol Genet Metab (2012) 0.77
Population analysis of the GLB1 gene in South Brazil. Genet Mol Biol (2011) 0.75
Insights into post-translational processing of beta-galactosidase in an animal model resembling late infantile human G-gangliosidosis. J Cell Mol Med (2007) 0.75
Regulation of lysosomal ion homeostasis by channels and transporters. Sci China Life Sci (2016) 0.75
Comparison of HCMV IE and EF-1 promoters for the stable expression of beta-subunit of hexosaminidase in CHO cell lines. Biochem Genet (2006) 0.75
Three novel beta-galactosidase gene mutations in Han Chinese patients with GM1 gangliosidosis are correlated with disease severity. J Biomed Sci (2010) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (1985) 95.08
Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem (1973) 24.38
Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics (1989) 19.10
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A (1987) 18.91
A classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem J (1991) 14.56
New families in the classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem J (1993) 11.10
Protein oligomerization in the endoplasmic reticulum. Annu Rev Cell Biol (1989) 8.22
Control of protein exit from the endoplasmic reticulum. Annu Rev Cell Biol (1989) 7.31
Three-dimensional structure of beta-galactosidase from E. coli. Nature (1994) 3.46
Alternative splicing of beta-galactosidase mRNA generates the classic lysosomal enzyme and a beta-galactosidase-related protein. J Biol Chem (1989) 2.91
Transport of secretory and membrane glycoproteins from the rough endoplasmic reticulum to the Golgi. A rate-limiting step in protein maturation and secretion. J Biol Chem (1988) 2.63
Biochemical consequences of mutations causing the GM2 gangliosidoses. Biochim Biophys Acta (1999) 1.95
Vectors used for expression in mammalian cells. Methods Enzymol (1990) 1.74
Cloning, sequencing, and expression of cDNA for human beta-galactosidase. Biochem Biophys Res Commun (1988) 1.55
Protocols for an improved detection of point mutations by SSCP. Nucleic Acids Res (1991) 1.50
Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr Rev (1998) 1.47
Glycosidase families. Biochem Soc Trans (1998) 1.43
Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein. Biochim Biophys Acta (1999) 1.16
A Pro504 --> Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease. J Biol Chem (1998) 1.15
Molecular cloning of mouse acid beta-galactosidase cDNA: sequence, expression of catalytic activity and comparison with the human enzyme. Biochem Biophys Res Commun (1990) 1.14
The chromosomal localization of human beta-galactosidase revisited: a locus for beta-galactosidase on human chromosome 3 and for its protective protein on human chromosome 22. Hum Genet (1985) 1.10
Identification of Glu-268 as the catalytic nucleophile of human lysosomal beta-galactosidase precursor by mass spectrometry. J Biol Chem (1997) 0.98
Families, superfamilies and subfamilies of glycosyl hydrolases. Biochem J (1995) 0.98
Protein processing: a role in the pathophysiology of genetic disease. FEBS Lett (1997) 0.95
Human placental beta-galactosidase. Characterization of the dimer and complex forms of the enzyme. Biochem J (1992) 0.95
Kinetic mechanism and characterization of human beta-galactosidase precursor secreted by permanently transfected Chinese hamster ovary cells. Biochem J (1994) 0.90
Organization of the gene encoding human lysosomal beta-galactosidase. DNA Cell Biol (1991) 0.87
Enzymes as chaperones and chaperones as enzymes. FEBS Lett (1998) 0.86
Early proteolytic cleavage with loss of a C-terminal fragment underlies altered processing of the beta-galactosidase precursor in galactosialidosis. Biochem J (1996) 0.86
Six novel beta-galactosidase gene mutations in Brazilian patients with GM1-gangliosidosis. Hum Mutat (1999) 0.84
The Morquio syndrome: neuropathology and biochemistry. Ann Neurol (1978) 0.83
Processing of normal lysosomal and mutant N-acetylgalactosamine 4-sulphatase: BiP (immunoglobulin heavy-chain binding protein) may interact with critical protein contact sites. Biochem J (1999) 0.82
Purification and characterization of human liver beta-galactosidase from a patient with the adult form of GM1 gangliosidosis and a normal control. Biochim Biophys Acta (1988) 0.81
Mutations in acid beta-galactosidase cause GM1-gangliosidosis in American patients. Am J Hum Genet (1993) 0.80
Cardiac involvement in diseases characterized by beta-galactosidase deficiency. J Pediatr (1985) 0.78
Comparison of the canine and human acid beta-galactosidase gene. Am J Med Genet (1996) 0.78
Morquio disease, type B: activation of GM1-beta-galactosidase by GM1-activator protein. Biochem Biophys Res Commun (1982) 0.78
Synergism of carbenicillin and gentamicin against enterococci. Antimicrob Agents Chemother (1973) 2.60
Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet (1992) 2.41
Comparative pharmacokinetics of amikacin and kanamycin. Clin Pharmacol Ther (1974) 2.15
Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus. J Infect Dis (1975) 1.94
Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS). J Inherit Metab Dis (2009) 1.89
Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests. N Engl J Med (1990) 1.78
Pancreatitis in patients with organic acidemias. J Pediatr (1994) 1.73
Postanesthetic apnea in full-term infants after pyloromyotomy. Anesthesiology (1994) 1.67
Actin filaments participate in the relocalization of phosphatidylinositol3-kinase to glucose transporter-containing compartments and in the stimulation of glucose uptake in 3T3-L1 adipocytes. Biochem J (1998) 1.57
Copper-histidine therapy for Menkes disease. J Pediatr (1993) 1.56
Ligand affinity of the 67-kD elastin/laminin binding protein is modulated by the protein's lectin domain: visualization of elastin/laminin-receptor complexes with gold-tagged ligands. J Cell Biol (1991) 1.48
Nerve biopsy findings in Niemann-Pick type II (NPC) Acta Neuropathol (1994) 1.45
Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease. Am J Hum Genet (1991) 1.44
A simple method for the maintenance of oxygen saturation following intravenous induction of anaesthesia with propofol. Anaesthesia (1994) 1.39
The conversion of phenylalanine to tyrosine in man. Direct measurement by continuous intravenous tracer infusions of L-[ring-2H5]phenylalanine and L-[1-13C] tyrosine in the postabsorptive state. Metabolism (1982) 1.38
Enzyme replacement therapy by renal allotransplantation in Fabry's disease. N Engl J Med (1972) 1.38
Ticarcillin vs carbenicillin: clinical pharmacokinetics. Clin Pharmacol Ther (1975) 1.37
The 67-kDa enzymatically inactive alternatively spliced variant of beta-galactosidase is identical to the elastin/laminin-binding protein. J Biol Chem (1998) 1.36
Early-infantile galactosialidosis: prenatal presentation and postnatal follow-up. Am J Med Genet (1999) 1.31
Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients. Am J Med Genet (1998) 1.31
Barth syndrome: clinical observations and genetic linkage studies. Am J Med Genet (1994) 1.31
Solar wind dynamic pressure and electric field as the main factors controlling Saturn's aurorae. Nature (2005) 1.30
Arteriopathy and coarctation of the abdominal aorta in children with mucopolysaccharidosis: imaging findings. AJR Am J Roentgenol (1991) 1.29
Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin. Infection (1974) 1.28
Clinical pharmacology of amikacin and kanamycin. J Infect Dis (1976) 1.26
The elastin receptor shows structural and functional similarities to the 67-kDa tumor cell laminin receptor. J Biol Chem (1989) 1.24
Secretion of proteoglycans by chondrocytes. Influence of colchicine, cytochalasin B, and beta-D-xyloside. Arch Biochem Biophys (1979) 1.24
Pharmacokinetics of metronidazole as determined by bioassay. Antimicrob Agents Chemother (1974) 1.21
Decreased elastin deposition and high proliferation of fibroblasts from Costello syndrome are related to functional deficiency in the 67-kD elastin-binding protein. Am J Hum Genet (2000) 1.16
A Pro504 --> Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease. J Biol Chem (1998) 1.15
Elastin binds to a multifunctional 67-kilodalton peripheral membrane protein. Biochemistry (1989) 1.14
An Earth-like correspondence between Saturn's auroral features and radio emission. Nature (2005) 1.10
The endogenous vascular elastase that governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin. J Clin Invest (1994) 1.09
High-level gentamicin resistance in Enterococcus faecalis bacteremia. J Infect Dis (1991) 1.07
Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy. J Child Neurol (1995) 1.07
Funding crisis of the national health research and development program. Can Med Assoc J (1979) 1.07
Ceramide trihexosidosis (fabry's disease) without skin lesions. N Engl J Med (1971) 1.05
Early copper-histidine treatment for Menkes disease. Nat Genet (1996) 1.05
Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Pediatrics (1996) 1.01
Maternal phenylketonuria (PKU)--a review. Clin Biochem (1987) 1.00
Cartilage macromolecules and the calcification of cartilage matrix. Anat Rec (1989) 1.00
Development of immunoreagents to ciliary zonules that react with protein components of elastic fiber microfibrils and with elastin-producing cells. Biochem Biophys Res Commun (1988) 0.99
Ornithine transcarbamylase deficiency presenting with strokelike episodes. J Pediatr (1993) 0.99
Autosomal recessive inheritance of vasopressin-resistant diabetes insipidus. Am J Med Genet (1991) 0.98
Identification of Glu-268 as the catalytic nucleophile of human lysosomal beta-galactosidase precursor by mass spectrometry. J Biol Chem (1997) 0.98
Neutrophils show chemotaxis to type IV collagen and its 7S domain and contain a 67 kD type IV collagen binding protein with lectin properties. Am J Respir Cell Mol Biol (1989) 0.98
A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies. Hum Mutat (1992) 0.98
Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase. Am J Hum Genet (2000) 0.98
Amerindian pyruvate carboxylase deficiency is associated with two distinct missense mutations. Am J Hum Genet (1998) 0.96
Kinetics of receptor-mediated binding of tropoelastin to ligament fibroblasts. J Biol Chem (1988) 0.96
Human placental beta-galactosidase. Characterization of the dimer and complex forms of the enzyme. Biochem J (1992) 0.95
Sphingomyelinases in human tissues. II. Absence of a specific enzyme from liver and brain of Niemann-Pick disease, type C. Pediatr Res (1975) 0.95
Polyclonal antibodies to tropoelastin and the specific detection and measurement of tropoelastin in vitro. Connect Tissue Res (1991) 0.94
Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: a new cause for recurrent myoglobinuria and encephalopathy. Ann Neurol (1991) 0.94
Vitamin B12 deficiency in adolescents and young adults with phenylketonuria. Lancet (1993) 0.93
The calcification of cartilage matrix in chondrocyte culture: studies of the C-propeptide of type II collagen (chondrocalcin). J Cell Biol (1987) 0.93
Joubert syndrome with congenital hepatic fibrosis: an entity in the spectrum of oculo-encephalo-hepato-renal disorders. Am J Med Genet (1994) 0.93
Studies on the activation of the enzymatic hydrolysis of sphingomyelin liposomes. Biochim Biophys Acta (1984) 0.92
Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes. Neuropathol Appl Neurobiol (2007) 0.92
Infantile sialidosis: a phenocopy of type 1 GM1 gangliosidosis distinguished by genetic complementation and urinary oligosaccharides. Am J Hum Genet (1979) 0.92
Cholesterol esterification and Niemann-Pick disease: an approach to identifying the defect in fibroblasts. J Neurosci Res (1990) 0.92
Purification of sphingomyelinase to apparent homogeneity by using hydrophobic chromatography. Biochem J (1981) 0.92
Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues. J Clin Psychiatry (1995) 0.91
Catabolism of exogenous and endogenous sphingomyelin and phosphatidylcholine by homogenates and subcellular fractions of cultured neuroblastoma cells. Effects of anesthetics. J Neurochem (1985) 0.91
Human placental beta-galactosidase: structural and immunological observations. Can J Biochem Cell Biol (1984) 0.91
Ethylmalonic and methylsuccinic aciduria in ethylmalonic encephalopathy arise from abnormal isoleucine metabolism. Metabolism (1998) 0.91
Pulmonary infiltration in Niemann-Pick disease type C. J Inherit Metab Dis (1996) 0.90
Kinetic mechanism and characterization of human beta-galactosidase precursor secreted by permanently transfected Chinese hamster ovary cells. Biochem J (1994) 0.90
Fine structure of the golgi complex during mitosis of cartilaginous cells in vitro. Tissue Cell (1977) 0.90
Characteristics of the beta-galactosidase-carboxypeptidase complex in GM1-gangliosidosis and beta-galactosialidosis fibroblasts. Biochem J (1992) 0.90
The biochemistry and clinical features of galactosialidosis. Biochim Biophys Acta (1994) 0.90
Evolution of the neuroimaging changes in fucosidosis type II. J Inherit Metab Dis (1996) 0.89
Vitamin B12 deficiency in adolescents and young adults with phenylketonuria. Eur J Pediatr (1996) 0.89
Enzymatic hydrolysis of sphingomyelin liposomes by normal tissues and tissues from patients with Niemann-Pick disease. Biochim Biophys Acta (1983) 0.89
Tropoelastin and elastin degradation products promote proliferation of human astrocytoma cell lines. J Neuropathol Exp Neurol (1998) 0.89
Glaucoma as an early complication of Hurler's disease. Arch Dis Child (1988) 0.89
The effect of vincristine on skeletal muscle in the rat. A correlative histochemical, ultrastructural and chemical study. J Neuropathol Exp Neurol (1972) 0.89
Astrocytoma cell interaction with elastin substrates: implications for astrocytoma invasive potential. Glia (1999) 0.88
Sphingomyelinases in human tissues. III. Expression of Niemann-Pick disease in cultured skin fibroblasts. Pediatr Res (1975) 0.88
Proteolytic activity of human non-Hodgkin's lymphomas. Am J Pathol (1998) 0.88
Homozygous presence of the crossover (fusion gene) mutation identified in a type II Gaucher disease fetus: is this analogous to the Gaucher knock-out mouse model? Biochem Med Metab Biol (1994) 0.88
The active site of lysosomal sphingomyelinase: evidence for the involvement of hydrophobic and ionic groups. J Neurosci Res (1983) 0.87
Isoenzymes of sphingomyelinase and the genetic defect in Niemann-Pick disease, type C. Biochem Biophys Res Commun (1974) 0.87
Angiokeratoma corporis diffusum (Anderson-Fabry disease) in a single large family in Nova Scotia. J Med Genet (1978) 0.87
Pathways of sphingomyelin metabolism in cultured fibroblasts from normal and sphingomyelin lipidosis subjects. J Biol Chem (1983) 0.87
Feto-maternal plasma phenylalanine concentration gradient from 19 weeks gestation to term. Clin Chim Acta (1994) 0.87
Defective bone formation by transplanted Hyp mouse bone cells into normal mice. Endocrinology (1988) 0.87
The Val192Leu mutation in the alpha-subunit of beta-hexosaminidase A is not associated with the B1-variant form of Tay-Sachs disease. Am J Hum Genet (1996) 0.87
Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease. Am J Hum Genet (1996) 0.87
In vitro activation of neuraminidase in the beta-galactosidase-neuraminidase-protective protein complex by cathepsin C. Biochem Biophys Res Commun (1988) 0.87
Neutral glycosphingolipids of serum lipoproteins in Fabry's disease. Biochim Biophys Acta (1976) 0.86
Experience with adolescents with phenylketonuria returned to phenylalanine-restricted diets. J Am Diet Assoc (1986) 0.86
"Hypotyrosinemia" in phenylketonuria. Mol Genet Metab (2000) 0.86
A pulsating auroral X-ray hot spot on Jupiter. Nature (2002) 0.86
Early proteolytic cleavage with loss of a C-terminal fragment underlies altered processing of the beta-galactosidase precursor in galactosialidosis. Biochem J (1996) 0.86
Salmonella arizonae bacteremia as the presenting manifestation of human immunodeficiency virus infection following rattlesnake meat ingestion. Rev Infect Dis (1990) 0.86